Datavault AI and Wellgistics Health Partner on Blockchain Drug Tracking System
Datavault AI and Wellgistics Health are collaborating to integrate blockchain technology into prescription drug tracking, aiming to improve transparency, efficiency, and patient safety in pharmaceutical distribution.
Datavault AI and Wellgistics Health have signed a non-binding letter of intent to integrate blockchain technology into prescription drug tracking systems. The partnership will see DataVault's PharmacyChain smart contract technology implemented into Wellgistics' pharmaceutical distribution infrastructure, creating a digital tracking system that follows prescriptions from initial script to final fulfillment.
The collaboration represents a significant step toward modernizing pharmaceutical supply chains through blockchain verification. By digitizing the entire prescription process, the companies aim to ensure accurate, transparent and efficient medication delivery while supporting patient safety and optimized health outcomes. The technology could potentially reduce medication errors, prevent counterfeit drugs from entering the supply chain, and provide real-time visibility into prescription status.
Financial terms of the partnership include exploration of a revenue-sharing model based on PharmacyChain usage fees, with definitive terms to be determined following further negotiation between the companies. This business model suggests both companies see long-term value in blockchain-enabled pharmaceutical tracking beyond the initial implementation phase.
The integration addresses growing concerns about pharmaceutical supply chain security and transparency. With prescription drug abuse and counterfeit medications becoming increasing problems in healthcare, blockchain technology offers an immutable record that could help verify legitimate prescriptions and track medication movement from manufacturer to patient. The system's potential to create an auditable trail could also help healthcare providers and regulators monitor prescription patterns and identify potential issues earlier.
For more information about Datavault AI's technology platform, visit https://www.datavaultsite.com. Additional disclosures and terms applicable to this announcement can be found at http://IBN.fm/Disclaimer. The partnership between these technology and healthcare distribution companies represents the continuing convergence of digital innovation and healthcare delivery, potentially setting new standards for prescription safety and efficiency in the pharmaceutical industry.